<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Sophie Lutter</submitter><journal>The Journal of Cell Biology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-JCBD-201110132</full_dataset_link><attach_to>JCB</attach_to><legend>Confocal z-stack of wild-type mouse ear skin at P14 stained with antibodies against LYVE-1 (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type  mouse mesentery at postnatal day 16 stained with antibodies against Reelin (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Montage of confocal images (maximum intensity projections of z-stacks) showing a dermal collecting lymphatic vessel in the ear of a 3-week old Apoer2;Vldlr double mutant mouse from proximal (right) to distal (left) end. The tissue was stained with antibodies against LYVE-1 (green), aSMA (red) and podoplanin (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P16 stained with antibodies against LYVE-1 (green), desmin (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P12 stained with antibodies against LYVE-1 (green), desmin (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P21 showing uptake of intradermally injected FITC-dextran (green) into dermal lymphatic vessels, stained with antibodies against LYVE-1 (red) and aSMA (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P16 stained with antibodies against Laminin-a5 (green), aSMA (red) and LYVE-1 (blue).</legend><legend>Confocal z-stack of Reln mutant mouse collecting vessel stained with antibodies against LYVE-1 (green), aSMA (red) and podoplanin (blue).</legend><legend>Confocal z-stack of Reln mutant mouse collecting vessel stained with antibodies against Integrin-a9 (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P21 stained with antibodies against NG2 (green), aSMA (red) and podoplanin (blue).</legend><legend>Montage of confocal images showing a dermal collecting lymphatic vessel in the P20 ear of a wild-type mouse from proximal (right) to distal (left) end. The tissue was stained with antibodies against LYVE-1 (blue), aSMA (red) and podoplanin (green).</legend><legend>Confocal z-stack of wild-type mouse skin at postnatal day 21 stained with antibodies against Reelin (green) and PECAM-1 (red). The tissue was not permeabilised, and Reelin staining was amplified using the TSA system.</legend><legend>Montage of confocal images (maximum intensity projections of z-stacks) showing a dermal collecting lymphatic vessel in the ear of a 3-week old Dab1 mutant mouse from proximal (right) to distal (left) end. The tissue was stained with antibodies against LYVE-1 (green), aSMA (red) and podoplanin (blue).</legend><legend>Confocal z-stack of wild-type mouse skin at embryonic day 16 stained with antibodies against Reelin (green), LYVE-1 (red) and PECAM-1 (blue).</legend><legend>Western blot analysis of PECAM-1 expression. The left three lanes represent the samples that were analysed by immunoprecipitation with anti-Reln antibody in the other panels of this figure part.</legend><legend>Confocal z-stack of wild-type mouse ear skin at P12 stained with antibodies against LYVE-1 (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P14 stained with antibodies against Laminin-a5 (green), aSMA (red) and LYVE-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse mesentery at postnatal day 16 stained with antibodies against Reelin (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Left three lanes: analysis of cell lysates&lt;br />&lt;br />Right three lanes: analysis of culture supernatant</legend><legend>Confocal z-stack of wild-type mouse ear skin at P14 stained with antibodies against LYVE-1 (green), desmin (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of Reelin mutant mouse ear skin at P21 showing uptake of intradermally injected FITC-dextran (green) into dermal lymphatic vessels, stained with antibodies against LYVE-1 (red).</legend><legend>Montage of confocal images showing a dermal collecting lymphatic vessel in the P20 ear of a Reln mutant mouse from proximal (right) to distal (left) end. The tissue was stained with antibodies against LYVE-1 (blue), aSMA (red) and podoplanin (green).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P16 stained with antibodies against LYVE-1 (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse collecting vessel stained with antibodies against Integrin-a9 (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Montage of confocal images (maximum intensity projections of z-stacks) showing dermal collecting lymphatic vessel in the ear of a 3-week old wild-type mouse from proximal (right) to distal (left) end. The tissue was stained with antibodies against LYVE-1 (green), aSMA (red) and podoplanin (blue).</legend><legend>Immunoprecipitation with anti-Reelin antibody and Western blot analysis of lymphatic endothelial cell-conditioned medium with (left lane) or without (second lane from left) incubation with smooth muscle cells.</legend><legend>Confocal z-stack of Reelin mutant mouse ear skin at P21 showing uptake of intradermally injected FITC-dextran (green) into dermal lymphatic vessels, stained with antibodies against aSMA (red) and LYVE-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P21 stained with antibodies against desmin (green), aSMA (red) and podoplanin (blue).</legend><legend>Western blot analysis of aSMA expression. The left three lanes represent the samples that were analysed by immunoprecipitation with anti-Reln antibody in the other panels of this figure part.</legend><legend>Confocal z-stack of wild-type mouse ear skin at P21 showing uptake of intradermally injected FITC-dextran (green) into dermal lymphatic vessels, stained with antibodies against aSMA (red) and LYVE-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse collecting vessel stained with antibodies against LYVE-1 (green), aSMA (red) and podoplanin (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P14 stained with antibodies against collagen IV (green), aSMA (red) and LYVE-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse skin at postnatal day 21 stained with antibodies against Reelin (green), aSMA (red) and PECAM-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse ear skin at P16 stained with antibodies against collagen IV (green), aSMA (red) and LYVE-1 (blue).</legend><legend>Confocal z-stack of wild-type mouse collecting vessel stained with antibodies against LYVE-1 (green), aSMA (red) and PECAM-1 (blue).</legend><repository>bioimages</repository><figure_sub>Image 136084 (Figure 4 - F)</figure_sub><figure_sub>Image 136052 (Figure 1 - I)</figure_sub><figure_sub>Image 136096 (Figure 2 - E)</figure_sub><figure_sub>Image 136091 (Figure 3 - F)</figure_sub><figure_sub>Supplemental Figure 2</figure_sub><figure_sub>Image 136048 (Figure 1 - E)</figure_sub><figure_sub>Image 136050 (Figure 1 - F)</figure_sub><figure_sub>Image 136095 (Figure 2 - D)</figure_sub><figure_sub>Supplemental Figure 2 - E</figure_sub><figure_sub>Supplemental Figure 2 - F</figure_sub><figure_sub>Image 136051 (Figure 1 - H)</figure_sub><figure_sub>Image 136047 (Figure 1 - D)</figure_sub><figure_sub>Image 136049 (Figure 1 - G)</figure_sub><figure_sub>Image 136046 (Figure 1 - C)</figure_sub><figure_sub>Figure 1 - I</figure_sub><figure_sub>Figure 1 - H</figure_sub><figure_sub>Figure 1 - G</figure_sub><figure_sub>Image 136077 (Figure 5 - A)</figure_sub><figure_sub>Figure 1 - F</figure_sub><figure_sub>Figure 1 - L</figure_sub><figure_sub>Figure 1 - K</figure_sub><figure_sub>Figure 1 - J</figure_sub><figure_sub>Figure 1 - A</figure_sub><figure_sub>Image 136097 (Figure 2 - F)</figure_sub><figure_sub>Image 136079 (Figure 5 - B)</figure_sub><figure_sub>Figure 1 - E</figure_sub><figure_sub>Figure 1 - D</figure_sub><figure_sub>Image 136090 (Figure 3 - C: aSMA)</figure_sub><figure_sub>Figure 1 - C</figure_sub><figure_sub>Figure 1 - B</figure_sub><figure_sub>Figure 2 - G</figure_sub><figure_sub>Image 136059 (Figure 6 - E)</figure_sub><figure_sub>Figure 2 - E</figure_sub><figure_sub>Figure 2 - F</figure_sub><figure_sub>Image 136083 (Figure 4 - D)</figure_sub><figure_sub>Image 136080 (Figure 5 - D)</figure_sub><figure_sub>Image 136045 (Figure 1 - B)</figure_sub><figure_sub>Figure 2 - C</figure_sub><figure_sub>Image 136089 (Figure 3 - C: CD31)</figure_sub><figure_sub>Figure 2 - D</figure_sub><figure_sub>Figure 2 - A</figure_sub><figure_sub>Figure 2 - B</figure_sub><figure_sub>Figure 3 - F</figure_sub><figure_sub>Image 136087 (Figure 4 - I)</figure_sub><figure_sub>Image 136055 (Figure 1 - L)</figure_sub><figure_sub>Image 136044 (Figure 1 - A)</figure_sub><figure_sub>Image 136093 (Figure 2 - B)</figure_sub><figure_sub>Image 136098 (Figure 2 - G)</figure_sub><figure_sub>Figure 3 - C: aSMA</figure_sub><figure_sub>Figure 3 - C: CD31</figure_sub><figure_sub>Figure 3 - C,D: Reln</figure_sub><figure_sub>Figure 4 - I</figure_sub><figure_sub>Figure 4 - G</figure_sub><figure_sub>Figure 4 - H</figure_sub><figure_sub>Image 136058 (Figure 6 - D)</figure_sub><figure_sub>Figure 4 - F</figure_sub><figure_sub>Figure 4 - D</figure_sub><figure_sub>Image 136276 (Supplemental Figure 2 - F)</figure_sub><figure_sub>Figure 5 - A</figure_sub><figure_sub>Image 136094 (Figure 2 - C)</figure_sub><figure_sub>Image 136088 (Figure 3 - C,D: Reln)</figure_sub><figure_sub>Image 136057 (Figure 6 - C)</figure_sub><figure_sub>Image 136086 (Figure 4 - H)</figure_sub><figure_sub>Image 136054 (Figure 1 - K)</figure_sub><figure_sub>Figure 5 - B</figure_sub><figure_sub>Figure 5 - C</figure_sub><figure_sub>Figure 5 - D</figure_sub><figure_sub>Figure 5</figure_sub><figure_sub>Image 136275 (Supplemental Figure 2 - E)</figure_sub><figure_sub>Figure 4</figure_sub><figure_sub>Figure 6</figure_sub><figure_sub>Image 136092 (Figure 2 - A)</figure_sub><figure_sub>Figure 6 - C</figure_sub><figure_sub>Figure 6 - D</figure_sub><figure_sub>Image 136085 (Figure 4 - G)</figure_sub><figure_sub>Image 136053 (Figure 1 - J)</figure_sub><figure_sub>Image 136078 (Figure 5 - C)</figure_sub><figure_sub>Figure 1</figure_sub><figure_sub>Figure 3</figure_sub><figure_sub>Figure 6 - E</figure_sub><figure_sub>Figure 2</figure_sub><pubmed_authors>Sherry Xie</pubmed_authors><pubmed_authors>Taija Makinen</pubmed_authors><pubmed_authors>Sophie Lutter</pubmed_authors><pubmed_authors>Florence Tatin</pubmed_authors></additional><is_claimable>false</is_claimable><name>Smooth muscle–endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation</name><description/><dates><release>2012-06-04T11:22:38Z</release><modification>2018-11-29T11:22:38Z</modification><creation>2018-11-29T11:22:38Z</creation></dates><accession>S-JCBD-201110132</accession><cross_references><doi>10.1083/jcb.201110132</doi></cross_references></HashMap>